We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

84 hedge funds and large institutions have $11M invested in Ampio Pharmaceuticals Inc. in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,814% more call options, than puts

Call options by funds: $204K | Put options by funds: $7K

52% more capital invested

Capital invested by funds: $7.24M → $11M (+$3.76M)

13% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 15

6% less funds holding

Funds holding: 89 → 84 (-5)

50% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 10

Holders
84
Holders Change
-5
Holders Change %
-5.62%
% of All Funds
1.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
17
Reduced
15
Closed
10
Calls
$204K
Puts
$7K
Net Calls
+$197K
Net Calls Change
-$4K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$332K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$316K
3
WS
Wedbush Securities
California
+$187K
4
Northern Trust
Northern Trust
Illinois
+$76.6K
5
RJA
Raymond James & Associates
Florida
+$62.9K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$109K
2
GCP
GSA Capital Partners
United Kingdom
-$60.6K
3
Citadel Advisors
Citadel Advisors
Florida
-$57.9K
4
UBS Group
UBS Group
Switzerland
-$44K
5
Group One Trading
Group One Trading
Illinois
-$37K
Name Holding Trade Value Shares
Change 		Change in
Stake
APA
76
American Portfolios Advisors
New York
$1.69K – – –
Royal Bank of Canada
77
Royal Bank of Canada
Ontario, Canada
$1K -$171 -1 -13%
AF
78
Allworth Financial
California
$1K – – –
CAGAS
79
Capital Advisory Group Advisory Services
Minnesota
$1K – – –
CFG
80
Citizens Financial Group
Rhode Island
$1K – – –
CTB
81
Country Trust Bank
Illinois
$1K – – –
MFW
82
Mosaic Family Wealth
Missouri
$1K – – –
MA
83
MUFG Americas
New York
$1K – – –
GEA
84
Glen Eagle Advisors
New Jersey
$562 – – –
UBS Group
85
UBS Group
Switzerland
– -$44K -371 Closed
HAG
86
HighPoint Advisor Group
Illinois
– -$33K -178 Closed
Invesco
87
Invesco
Georgia
– -$15K -123 Closed
PAG
88
Private Advisor Group
New Jersey
– -$8K -68 Closed
BMO
89
Beck Mack & Oliver
New York
– -$5K -42 Closed
LPC
90
Loeb Partners Corp
New York
– -$2K -17 Closed
MAM
91
Meeder Asset Management
Ohio
– -$2K -16 Closed
BCM
92
Brasada Capital Management
Texas
– -$1K -6 Closed
Bank of Montreal
93
Bank of Montreal
Ontario, Canada
– -$1K -5 Closed
1 2 3
4

AMPE Hedge Fund Activity: Q1 2019 in Review

84 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2019, worth a combined $11M — up 52% from $7.24M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of AMPE and 5 opened new positions — a net loss of 5 holders — while 15 trimmed existing stakes and 17 added.

The largest buyer was BlackRock, adding an estimated $332K. The largest seller was Morgan Stanley, cutting an estimated $109K.

  • 84 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2019, down from 89 in Q4 2018.
  • Funds reported $11M of Ampio Pharmaceuticals Inc. stock for Q1 2019, up 52% quarter-over-quarter.
  • 5 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2019 and 10 closed out, a net change of -5 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q1 2019 was BlackRock, an estimated $332K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q1 2019 was Morgan Stanley, an estimated $109K sold.

Based on aggregated 13F filings for Q1 2019.